Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Placebo for Women in Spontaneous Preterm Labor

NCT02377466 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02377466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02377466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
February 29, 2016
Completion date
July 24, 2017
Enrollment
25 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

obstetric labour, premature